Vekovia · 17.09.2026
Follow the transformation, not the headline
Pomegranate contains compounds that certain gut microbes can transform into urolithins. Eating the precursor is therefore different from taking a measured amount of the resulting metabolite. A label saying ‘pomegranate extract’ is not a declaration of urolithin A content.
That distinction is useful whenever a supplement borrows the reputation of a related ingredient. First ask what is actually in the formula. Then ask whether that exact preparation was used in the study.
People do not all respond alike
Li and colleagues studied 20 healthy volunteers taking a particular pomegranate extract for four weeks. Urolithin A formation differed between participants; it was not induced in everyone. The study illustrates variation, not a reliable conversion factor from an extract dose to a urolithin dose.
It also reported differences in Akkermansia between urolithin producers and non-producers. A difference between groups does not show that any pomegranate product will increase that bacterium in an individual.
Where pomegranate fits in the formulas
The capsule formula specifies 500 mg pomegranate extract standardised to 40% ellagic acid in Cranberry & Pomegranate. Microbiome Complex specifies 300 mg of that extract. Neither formula lists urolithin A as an ingredient.
The fruit extract brings a defined botanical component to the formula. Its relationship with gut microbes is an interesting reason to study it, while individual conversion to urolithins remains variable. It is not a measured urolithin dose or a demonstrated longevity outcome.
Sources you can open
Li et al. (2015): Pomegranate extract, metabolites and stool microbiota ↗Ingredient research does not establish a clinical benefit for this finished formula.